TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36419197

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 103
Study: 32208487

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 34803148

Group type: COMPARATOR
Intervention: Glyceryl trinitrate ointment
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Tocopherol acetate ointment
Number of subjects: 160
Study: 32179428

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 90

Group type: COMPARATOR
Intervention: sham tDCS
Number of subjects: 90
Study: 35754107

Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 15
Study: 32885566

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives (COCs)
Number of subjects: 425
Study: 32950726

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) on dorsum of tongue
Number of subjects: 45

Group type: COMPARATOR
Intervention: Tongue scrappers (TS)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tongue scrappers (TS) and adjunctive PDT
Number of subjects: 45
Study: 36203161

Group type: EXPERIMENTAL
Intervention: Palliative care symptoms (IPOS)
Number of subjects: 37
Study: 34342185

Group type: EXPERIMENTAL
Intervention: Genetically predicted alcohol consumption (based on ALDH2 rs671 polymorphism)
Number of subjects: 8922

Group type: EXPERIMENTAL
Intervention: Observational analysis of alcohol consumption
Number of subjects: 8922

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 8922
Study: 32545534

Group type: EXPERIMENTAL
Intervention: SR-MRehab: Un colegio emocionante (virtual reality intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard self-regulation program (control)
Number of subjects: 0
Study: 35969196

Group type: COMPARATOR
Intervention: Frictionless group using T-loop springs
Number of subjects: 30
Study: 34922510

Group type: EXPERIMENTAL
Intervention: Little Holy One intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (12 lessons taught by Indigenous community health workers)
Number of subjects: 0
Study: 35130512

Group type: EXPERIMENTAL
Intervention: Low-intensity training group (LITG, n = 20)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: High-intensity training group (HITG, n = 24)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standardized training period (after intervention)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Self-chosen training period (after standardized training)
Number of subjects: 44
Study: 33650298

Group type: EXPERIMENTAL
Intervention: Intermittent exercise (IE)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Continuous exercise (CE)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (nonexercise)
Number of subjects: 8
Study: 32167679

Group type: EXPERIMENTAL
Intervention: Sacubitril–valsartan treatment
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Eligible group for sacubitril–valsartan
Number of subjects: 799
Study: 32755218

Group type: EXPERIMENTAL
Intervention: Medial meniscal extrusion (MME) threshold of 2.5 mm
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Medial meniscal extrusion (MME) threshold of 2.7 mm
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Medial meniscal extrusion (MME) threshold of 2.8 mm
Number of subjects: 235
Study: 32050916

Group type: EXPERIMENTAL
Intervention: Moisturising oil
Number of subjects: 15

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 15
Study: 35113424

Group type: EXPERIMENTAL
Intervention: Vaginal delivery (NG)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Cesarean group (CG)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Both groups (NG and CG)
Number of subjects: 105
Study: 34405547

Group type: EXPERIMENTAL
Intervention: Trilaciclib
Number of subjects: 3
Study: 35504519

Group type: EXPERIMENTAL
Intervention: Periosteal Pocket Flap Technique (PPF)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Guided Bone Regeneration (GBR)
Number of subjects: 9
Study: 32858622

Group type: EXPERIMENTAL
Intervention: Young group (15-39 years old)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Senior group (65-90 years old)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Mean day and night values
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 140
Study: 34599476

Group type: EXPERIMENTAL
Intervention: Behavioural intervention (1 month of theoretical and practical counselling once a year for 3 years)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 300
Study: 34157479

Group type: EXPERIMENTAL
Intervention: Seat comfort (Type A)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Seat comfort (Type B)
Number of subjects: 54
Study: 34118638

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: N/A (not applicable)
Number of subjects: 0
Study: 35333880

Group type: EXPERIMENTAL
Intervention: 2 mg moxidectin
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 4 mg moxidectin
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 8 mg moxidectin
Number of subjects: 98

Group type: COMPARATOR
Intervention: ivermectin
Number of subjects: 98
Study: 33833172

Group type: EXPERIMENTAL
Intervention: Autologous Fat Grafting (AFG)
Number of subjects: 57

Group type: COMPARATOR
Intervention: No Autologous Fat Grafting (Control)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 57
Study: 35295203

Group type: EXPERIMENTAL
Intervention: TCM oral therapy combined with medicinal bath
Number of subjects: 712

Group type: COMPARATOR
Intervention: TCM oral therapy
Number of subjects: 712
Study: 36079817

Group type: EXPERIMENTAL
Intervention: Potassium nitrate (10 mmol, 625 mg of nitrate)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (iso-molar potassium chloride)
Number of subjects: 18
Study: 33254235

Group type: EXPERIMENTAL
Intervention: Fostamatinib 100 mg bid (group A)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Fostamatinib 100 mg bid, then 150 mg qd (group B)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Fostamatinib (groups A and B)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Fostamatinib (group A)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo (group E)
Number of subjects: 130
Study: 32663055

Group type: EXPERIMENTAL
Intervention: Mindfulness induction
Number of subjects: 287

Group type: COMPARATOR
Intervention: Mind-wandering induction
Number of subjects: 287

Group type: COMPARATOR
Intervention: Join-the-dots task
Number of subjects: 287
Study: 35932889

Group type: EXPERIMENTAL
Intervention: Immediate telephone smoking cessation support (TSI) for 6 weeks with pharmacotherapy
Number of subjects: 315

Group type: COMPARATOR
Intervention: Usual care (UC) - very brief advice to quit and signposting to smoking cessation services
Number of subjects: 315
Study: 32209122

Group type: EXPERIMENTAL
Intervention: Acipimox
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 36095157

Group type: EXPERIMENTAL
Intervention: Exercise training + neuromuscular electrical stimulation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Exercise training alone
Number of subjects: 48
Study: 34425814

Group type: EXPERIMENTAL
Intervention: POC Xpert® HIV‐1 Qual test (Cepheid, Sunnyvale, CA, USA) for early infant diagnosis (EID)
Number of subjects: 45
Study: 34798531

Group type: EXPERIMENTAL
Intervention: Endometrial Scratching (ES) using pipelle's canula on D8 or D9 of menstrual cycle, followed by three cycles of ovulation induction with Clomiphene citrate and gonadotrophins and IUI
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (no endometrial scratching)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Endometrial Scratching (ES)
Number of subjects: 168
Study: 34172267

Group type: EXPERIMENTAL
Intervention: Unreamed intramedullary nail (UIMN)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bridge-plating (BP)
Number of subjects: 80
Study: 36243929

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50000 IU cholecalciferol weekly for three months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study: 33778854

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention (BI), n = 109
Number of subjects: 214

Group type: COMPARATOR
Intervention: Sales ban only, n = 105
Number of subjects: 214

Group type: COMPARATOR
Intervention: Sales ban only (for individuals with stronger cravings)
Number of subjects: 214
Study: 32791030

Group type: EXPERIMENTAL
Intervention: Castration with docetaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Castration without docetaxel
Number of subjects: 0
Study: 34724670

Group type: EXPERIMENTAL
Intervention: 3 seconds freezing time
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 4 seconds freezing time
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 5 seconds freezing time
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 6 seconds freezing time
Number of subjects: 100
Study: 33331448

Group type: EXPERIMENTAL
Intervention: Fasted (FASTED, n=13)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Fed (FED, n=12)
Number of subjects: 25
Study: 35476115

Group type: EXPERIMENTAL
Intervention: Ibuprofen (10 mg/kg child weight)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32710862

Group type: EXPERIMENTAL
Intervention: Quality improvement package for intrapartum and immediate newborn care, including provider mentoring using PRONTO simulation and team training, and quality improvement collaboratives.
Number of subjects: 2938

Group type: COMPARATOR
Intervention: Control group receiving maternity register data strengthening and a modified WHO Safe Childbirth Checklist.
Number of subjects: 2938
Study: 36085409

Group type: EXPERIMENTAL
Intervention: Sub-marginal instrumentation before surgical treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Supra-marginal instrumentation only
Number of subjects: 42
Study: 34246761

Group type: EXPERIMENTAL
Intervention: Full-treatment group (8 weeks of binocular treatment using therapeutic software application in virtual reality headset)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham-crossover group (4 weeks of sham treatment followed by 4 weeks of binocular treatment)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Full-treatment group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham-crossover group
Number of subjects: 20
Study: 35956935

Group type: COMPARATOR
Intervention: NanoBEO (essential oil of bergamot) administered as a single therapeutic dose via an airless dispenser.
Number of subjects: 0
Study: 33823257

Group type: EXPERIMENTAL
Intervention: CYDAR image fusion guidance
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard 2D fluoroscopy
Number of subjects: 37
Study: 32171512

Group type: EXPERIMENTAL
Intervention: Colostrum (COL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Whole Milk (WM)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1:1 Colostrum:Milk Mixture (MIX)
Number of subjects: 24
Study: 36118977

Group type: EXPERIMENTAL
Intervention: Theta-burst stimulation (TBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34785535

Group type: EXPERIMENTAL
Intervention: Fenofibrate therapy
Number of subjects: 4996

Group type: COMPARATOR
Intervention: No fenofibrate therapy
Number of subjects: 4996
Study: 33399379

Group type: EXPERIMENTAL
Intervention: Propofol with concrete words
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sevoflurane with abstract words
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no words)
Number of subjects: 75
Study: 32404062

Group type: EXPERIMENTAL
Intervention: Probiotics administered twice daily during antibiotic treatment for up to 1 week after completion of antibiotics
Number of subjects: 93

Group type: COMPARATOR
Intervention: No probiotics supplementation
Number of subjects: 93
Study: 35694717

Group type: EXPERIMENTAL
Intervention: Patient-directed regimen (individualized volume of polyethylene glycol based on stool consistency or water content)
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Patient-directed regimen
Number of subjects: 531

Group type: COMPARATOR
Intervention: Fixed-volume group (standard volume of polyethylene glycol)
Number of subjects: 531

Group type: COMPARATOR
Intervention: Fixed-volume group
Number of subjects: 531
Study: 35121932

Group type: EXPERIMENTAL
Intervention: Flt3 ligand (CDX-301) pre-treatment with anti-DEC-205-NY-ESO-1 vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (anti-DEC-205-NY-ESO-1 vaccine without Flt3 ligand)
Number of subjects: 0
Study: 36171631

Group type: EXPERIMENTAL
Intervention: Robotic-assisted distal gastrectomy (RADG)
Number of subjects: 1164

Group type: COMPARATOR
Intervention: Laparoscopic-assisted distal gastrectomy (LADG)
Number of subjects: 1164
Study: 34032900

Group type: EXPERIMENTAL
Intervention: High protein intake (> 2.1 g protein/kg lean body mass/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Recommended protein intake (1.1 g protein/kg lean body mass/day)
Number of subjects: 11
Study: 32416309

Group type: EXPERIMENTAL
Intervention: Supervised Exercise Therapy (SET) - three times weekly supervised treadmill exercise
Number of subjects: 309

Group type: COMPARATOR
Intervention: Control - lectures on health-related topics
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Supervised Exercise Therapy (SET) - participants attending at least 70% of sessions
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Supervised Exercise Therapy (SET) - participants with baseline six-minute walk distance less than median (334 meters)
Number of subjects: 309
Study: 34067261

Group type: EXPERIMENTAL
Intervention: Cobalt‐chrome‐based metal‐ceramic prostheses (MC)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Cobalt‐chrome‐based metal‐ceramic prostheses using CAD/CAM (CC‐MC)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Zirconia‐based ceramic prostheses using CAD/CAM (CC‐Zr)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (MC, CC‐MC, CC‐Zr)
Number of subjects: 129
Study: 35723596

Group type: EXPERIMENTAL
Intervention: SSGL (3v3 in large fixed area)
Number of subjects: 12

Group type: COMPARATOR
Intervention: SSGS (3v3 in small fixed area)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SSGD (3v3 in dynamic dimensions)
Number of subjects: 12
Study: 33472390

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 72
Study: 32497736

Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil plus bevacizumab (TT–B)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Capecitabine plus bevacizumab (C–B)
Number of subjects: 153
Study: 616626291

Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery (ERAS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional treatment (control group)
Number of subjects: 60
Study: 35316121

Group type: EXPERIMENTAL
Intervention: Housing First (HF) program
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Housing First (HF) program (subgroup with severe mental illness)
Number of subjects: 87

Group type: COMPARATOR
Intervention: treatment-as-usual (TAU) group
Number of subjects: 87
Study: 32529966

Group type: EXPERIMENTAL
Intervention: Psychedelic-assisted therapy (psilocybin, LSD, ayahuasca, MDMA)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 9
Study: 35092084

Group type: EXPERIMENTAL
Intervention: RT‐VAR (manipulation of load, volume, muscle action, and rest interval at each RT session)
Number of subjects: 20

Group type: COMPARATOR
Intervention: RT‐CON (without specific variables manipulations)
Number of subjects: 20
Study: 33223453

Group type: EXPERIMENTAL
Intervention: ICGFC-LC
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional LC
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study: 32940866

Group type: EXPERIMENTAL
Intervention: LADS
Number of subjects: 20

Group type: COMPARATOR
Intervention: BPD/DS
Number of subjects: 20
Study: 36070760

Group type: EXPERIMENTAL
Intervention: Pain competence training with depression prevention (Debora)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Pain competence training without depression prevention (Control Group)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Combined training (Debora)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Patients with high levels of depressive symptoms
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Patients with low depressive symptoms
Number of subjects: 422
Study: 36100930

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBOT) - 90 min at 203 kPa daily for 20 days
Number of subjects: 59
Study: 32394723

Group type: EXPERIMENTAL
Intervention: Depot Medroxyprogesterone Acetate (DMPA‐IM)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Copper Intrauterine Device (IUD)
Number of subjects: 382
Study: 35731065

Group type: EXPERIMENTAL
Intervention: Aerobic training sessions on a cycle ergometer (50‐60% heart rate reserve, moderate intensity)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Selected physical therapy program only (Control group)
Number of subjects: 40
Study: 34480773

Group type: EXPERIMENTAL
Intervention: Five-session online imaginal exposure therapy (n=65)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control online writing and thinking intervention (n=65)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Imaginal exposure therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control online writing and thinking intervention
Number of subjects: 130
Study: 32755496

Group type: EXPERIMENTAL
Intervention: Wired portable amplifier (Device A)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Wireless stationary amplifier (Device B)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: One-way personal communication system (Device C)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No device
Number of subjects: 22
Study: 616119991

Group type: EXPERIMENTAL
Intervention: ETDRS PRP plus IVR (SS-PRP group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: PASCAL PRP plus IVR (MS-PRP group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Only IVR (IVR group)
Number of subjects: 44
Study: 34935979

Group type: EXPERIMENTAL
Intervention: Combined aerobic and neck-specific exercises
Number of subjects: 69
Study: 32295624

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg of body mass)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 34570916

Group type: EXPERIMENTAL
Intervention: Semaglutide 0.4 mg once-daily subcutaneous
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 32862194

Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 2

Group type: COMPARATOR
Intervention: Monopolar electrocautery
Number of subjects: 2
Study: 34254983

Group type: EXPERIMENTAL
Intervention: Mother's own milk
Number of subjects: 114

Group type: COMPARATOR
Intervention: Donor milk
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Maternal ethnicity
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Maternal prepregnancy BMI
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Maternal BMI ≥30
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Gestational age and income
Number of subjects: 114
Study: 35212023

Group type: EXPERIMENTAL
Intervention: 1 mg oral estradiol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Estradiol treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cognitive complaints (self-reported)
Number of subjects: 40
Study: 33765420

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg once daily
Number of subjects: 194

Group type: COMPARATOR
Intervention: Vitamin K antagonist (phenprocoumon, acenocoumarol, or warfarin; target INR 2.0-3.0) for 90 days
Number of subjects: 194

Group type: COMPARATOR
Intervention: Vitamin K antagonist
Number of subjects: 194
Study: 35524896

Group type: EXPERIMENTAL
Intervention: Viewing icon arrays illustrating side effect risk
Number of subjects: 2046

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2046
Study: 32017992

Group type: EXPERIMENTAL
Intervention: Expectant management at ≥37 weeks of gestation
Number of subjects: 5498

Group type: EXPERIMENTAL
Intervention: Spontaneous labor
Number of subjects: 5498

Group type: EXPERIMENTAL
Intervention: Induced labor
Number of subjects: 5498
Study: 35394123

Group type: EXPERIMENTAL
Intervention: 250-mg azithromycin test formulation
Number of subjects: 77

Group type: COMPARATOR
Intervention: 250-mg azithromycin reference formulation
Number of subjects: 77
Study: 34819147

Group type: EXPERIMENTAL
Intervention: Low-dose calcium supplementation (500 mg elemental calcium/day)
Number of subjects: 22000

Group type: COMPARATOR
Intervention: Standard high-dose calcium supplementation (1500 mg elemental calcium/day)
Number of subjects: 22000
Study: 35819099

Group type: EXPERIMENTAL
Intervention: Telerehabilitation group (n=29)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Telephone group (n=29)
Number of subjects: 58
Study: 34294051

Group type: EXPERIMENTAL
Intervention: Prenatal behavioral lifestyle intervention (PBLI) delivered via group based phone counseling (GBPC)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 41
Study: 35787963

Group type: EXPERIMENTAL
Intervention: Machine Learning models (random forest, support vector machine [SVM], logistic regression)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Corticosteroid Randomization After Significant Head Injury (CRASH) model
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Machine Learning models (random forest, SVM, logistic regression)
Number of subjects: 423